Semaglutide 1 vial (2 mg)

Semaglutide by Hilma Biocare is a modern, scientifically proven method of weight loss, also known under the name Ozempic. This weight loss method is suitable for both men and women and people who do not go to the gym at all. Weight loss occurs because the drug suppresses hunger and regulates blood sugar levels. In addition, semaglutide reduces the risk of diabetes.

Semaglutide reduces high blood sugar levels by increasing the amount of insulin released, decreasing the amount of glucagon released, and delaying gastric emptying. Semaglutide also controls appetite and helps reduce the amount of food a person wants to eat. In addition, Semaglutide reduces the preference for fatty foods.

The drug is used to reduce the risk of heart attack, stroke, and death in people who are overweight and have heart disease.

Specifications:

• Molecular formula: C187H291N45O59
• Molecular weight: 4113.641 g/mol
• CAS Number: 910463-68-2
• Form: Lyophilized (freeze-dried) powder for reconstruction, sterile solution
• Route of administration: Injection

Effects of taking Semaglutide

1. weight loss up to 8 kg in 3 months;
2. suppresses appetite;
3. improves metabolism;
4. stabilizes blood sugar levels;
5. Reduces inflammation, improves recovery.

How does Semaglutide work?

The drug reduces high blood sugar levels by increasing the amount of insulin released, decreasing the amount of glucagon released, and delaying gastric emptying. Semaglutide also controls appetite and helps reduce the amount of food a person wants to eat. In addition, Semaglutide reduces the preference for fatty foods.

In clinical studies, semaglutide had a positive effect on plasma lipids, reduced systolic blood pressure, and reduced inflammation. In animal studies, semaglutide slowed the development of atherosclerosis by preventing the progression of aortic plaque development and reducing plaque inflammation.

Use and dosage of Semaglutide

Dosage regimen (if you don’t have type 2 diabetes):

• 1 injection per week
• 1-2 weeks 0.25 mg
• 3-4 weeks 0.5 mg
• 5-8 weeks 1 mg
• From the 9th week, if necessary, it can be increased to 2 mg if there are no side effects.

For type 2 diabetics the course is smoother:

• 1 injection per week
• 1-4 weeks 0.25 mg
• 5-8 weeks 0.5 mg
• 9-12 weeks 1 mg
• 13+ weeks 2 mg

Side effects

• from the immune system: rarely - anaphylactic reactions;
• from the side of metabolism and nutrition: very often - hypoglycemia when used in combination with insulin or a sulfonylurea derivative; often - hypoglycemia when used in combination with other PHGD, decreased appetite;
• from the nervous system: often - dizziness, uncommon - dysgeusia;
• from the organ of vision: often - complications of diabetic retinopathy;
• from the cardiovascular system: increased heart rate;
• from the gastrointestinal tract: very often - nausea, diarrhea; often - vomiting, abdominal pain, bloating, constipation, dyspepsia, gastritis, gastroesophageal reflux disease, belching, flatulence;
• from the liver and biliary tract: often - cholelithiasis;
• local reactions: reactions at the injection site;
• systemic reactions: fatigue;
• laboratory and instrumental data: often - increased lipase activity, increased amylase activity, decreased body weight.

What to avoid

Tell your doctor if you have signs of a thyroid tumor, such as swelling or lump in your neck, difficulty swallowing, hoarseness, or shortness of breath.

You should not take semaglutide if you have multiple endocrine neoplasia type 2 (glandular tumors) or if you have a personal or family history of medullary thyroid cancer.

Talk to your doctor about taking semaglutide if you have ever had any of the following conditions:

• diabetic ketoacidosis;
• pancreatitis;
• kidney disease;
• vision problems caused by diabetes (retinopathy).